Clinical Significance of Hepatocyte Growth Factor and Transforming Growth Factor-Beta-1 Levels in Assessing Disease Activity in Inflammatory Bowel Disease

Table 1

Age, sex, and degree of disease activity in the CD group and the UC group.

	Groups
	CD group	UC group
Age	32.7 ± 11.63	32.68 ± 7.16
Sex			Total
Female	56 (56.00%)	39 (39.00%)	95 (47.50%)
Male	44 (44.00%)	61 (61.00%)	105 (52.50%)
Total	100 (100.00%)	100 (100.00%)	200 (100.00%)
Degree of disease activity			Total
Mild	25 (25.00%)	38 (38.00%)	63 (31.50%)
Moderate	40 (40.00%)	53 (53.00%)	93 (46.50%)
Severe	35 (35.00%)	9 (9.00%)	44 (22.00%)
Total	100 (100.00%)	100 (100.00%)	200 (100.00%)